Business · 29/10/2003
FDA Clears PIPRACIL Vials for Sale After Review
The FDA has cleared piperacillin sodium 2-gram, 3-gram, and 4-gram vials for sale after determining they were not withdrawn due to safety or effectiveness concerns, paving the way for approval of abbreviated new drug applications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →